Women with moderate to severe fibroids set to be offered new one-a-day treatment following final draft guidance from NICE
Around 4,500 women with uterine fibroids will be eligible for a new oral treatment after NICE recommended relugolix with estradiol and norethisterone acetate (also called Ryeqo and made by Gedeon Ritcher UK) in final draft guidance.
-
NICE outlines steps needed to put ME/CFS guideline into practice
NICE has today, International ME Awareness Day (Thursday, 12 May 2022) published its implementation statement which sets out the practical steps needed to put its recent guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) into
-
Healthier lifestyle can help to ease osteoarthritis symptoms says NICE
Exercise has an important role to play in helping people living with osteoarthritis NICE says in draft updated guidelines published today (29th April 2022) on the care and management of people with the condition.
-
Over 700 people a year could benefit from a new potentially life-extending lung cancer drug which targets a specific genetic mutation
New potentially life-extending lung cancer drug which targets a specific genetic mutation recommended by NICE
